PREVIOUS
✖
Mynvax
April 20 , 2022
857 days
529
0
- In India, a prospective vaccine against COVID-19 or SarsCov2 is being developed
- That doesn’t require refrigeration or stored in cold-chain storage.
- According to a study published in the peer-reviewed journal ‘Viruses’, the vaccine, in mouse trials has generated antibodies against various variants of the virus.
- This ‘warm’ vaccine is being developed by Mynvax laboratories, a Bengaluru-based company that was incubated at the Indian Institute of Science Bangalore.
- It is a unique vaccine that can be stored at 37 degrees Celsius for a period of four weeks and for up to 90 minutes at 100 degrees Celsius.
Leave a Reply
Your Comment is awaiting moderation.